Surgical Innovations Group plc
("Group" or the "Company")
Year-end Trading Update
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, is pleased to provide an update on trading for the year ended 31 December 2017.
Group revenue for the year exceeded £8.7m, representing growth of approximately 44% over 2016. Within this, organic growth in the existing business was approximately 10%. The integration of Elemental Healthcare Limited, acquired in August 2017, continues in line with plan and following the acquisition, the reaction of both distributors and suppliers to both businesses has been very positive.
The combined gross margins were within target range and the increasing levels of profitability are in line with board and market expectations.
Audited results for the year ended 31 December 2017 will be released in mid-March 2018.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
For further information please contact:
Surgical Innovations Group plc |
|
Nigel Rogers, Executive Chairman |
Tel: 0113 230 7597 |
Melanie Ross, COO & CFO |
|
|
|
WH Ireland Limited (NOMAD & Broker) |
Tel: 0113 394 6600 |
Tim Feather Alex Bond |
|
|
|
Walbrook PR (Financial PR & Investor Relations) |
Tel: 020 7933 8780 or si@walbrookpr.com |
Paul McManus |
Mob: 07980 541 893 |
Lianne Cawthorne |
Mob: 07584 391 303 |